Overview |
bs-0094R-Cy5 |
AACT Alpha1 Polyclonal Antibody, Cy5 Conjugated |
WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Mouse, Rat |
Human |
Specifications |
Cy5 |
Rabbit |
KLH conjugated synthetic peptide derived from human AACT-Alpha1 |
121-320/423 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
12 |
P01011 |
Secreted |
ACT; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; Cell growth-inhibiting gene 24/25 protein; Serpin A3; SERPINA3 |
Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2. |
Application Dilution |
WB |
1:300-5000 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |